1.97
-0.02 (-1.01%)
| Previous Close | 1.99 |
| Open | 2.28 |
| Volume | 7,951 |
| Avg. Volume (3M) | 11,670 |
| Market Cap | 12,233,779 |
| Price / Sales | 0.010 |
| Price / Book | 0.430 |
| 52 Weeks Range | |
| Earnings Date | 12 Feb 2021 |
| Profit Margin | -2.74% |
| Operating Margin (TTM) | -4.99% |
| Diluted EPS (TTM) | -2.81 |
| Quarterly Revenue Growth (YOY) | -0.20% |
| Total Debt/Equity (MRQ) | 304.16% |
| Current Ratio (MRQ) | 0.940 |
| Operating Cash Flow (TTM) | -3.16 M |
| Levered Free Cash Flow (TTM) | 3.53 M |
| Return on Assets (TTM) | -2.37% |
| Return on Equity (TTM) | -27.35% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
| Pharmaceutical Retailers (Global) | Mixed | Mixed | |
| Stock | China Jo-Jo Drugstores, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.5 |
| Average | -0.88 |
|
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment. |
|
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Investment Style | Small Value |
| % Held by Insiders | 38.35% |
| % Held by Institutions | 0.31% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 03 Feb 2025 | Announcement | China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |